Sunday, April 17, 2016

High Importance: Sterile Drug Products from Pharmakon Pharmaceuticals, Inc: CDER Statement - FDA alerts health care professionals not to use due to a lack of sterility assurance and other quality issues Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death

No comments: